IMMUNOTECH-B News

IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024

Aug 5 04:40 ET

IMMUNOTECH-B: RESIGNATION OF CHIEF FINANCIAL OFFICER,COMPANY SECRETARY AND AUTHORISED REPRESENTATIVEANDAPPOINTMENT OF JOINT COMPANY SECRETARIES ANDAUTHORISED REPRESENTATIVE ANDWAIVER FROM STRICT COMPLIANCEWITH RULES 3.28 AND 8.17 OF THE LISTING RULES

Jul 26 07:49 ET

IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024

Jul 3 04:51 ET

IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024

Jun 5 04:40 ET

IMMUNOTECH-B: FOURTH AMENDED AND RESTATEDMEMORANDUM AND ARTICLES OF ASSOCIATION

May 24 07:30 ET

IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

May 6 04:40 ET

IMMUNOTECH-B: FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON 24 MAY 2024

Apr 29 05:01 ET

IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 3 04:46 ET

IMMUNOTECH-B: PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM ANDARTICLES OF ASSOCIATION AND ADOPTION OFTHE FOURTH MEMORANDUM AND ARTICLES OF ASSOCIATION

Mar 28 09:39 ET

IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

Mar 5 07:30 ET

IMMUNOTECH-B: VOLUNTARY ANNOUNCEMENTTHE CLINICAL TRIAL APPROVAL FOR THE aT19 INJECTION

Feb 19 06:32 ET

IMMUNOTECH-B: Notification Letter to Non-registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications

Feb 5 03:46 ET

IMMUNOTECH-B: Notification Letter to Registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications

Feb 5 03:45 ET

IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

Feb 2 04:20 ET

IMMUNOTECH-B: VOLUNTARY ANNOUNCEMENTFIRST PATIENT ENROLLED IN THE PHASE II CLINICAL TRIALFOR CAR-T-19 INJECTION

Jan 3 06:33 ET

IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

Jan 3 03:40 ET

IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023

Dec 4, 2023 04:26 ET

IMMUNOTECH-B: VOLUNTARY ANNOUNCEMENTRECEIPT OF THE ACCEPTANCE NOTICE FOR THEINVESTIGATIONAL NEW DRUG APPLICATIONFOR THE aT19 INJECTION

Nov 24, 2023 06:17 ET

IMMUNOTECH-B: VOLUNTARY ANNOUNCEMENTFIRST PATIENT ENROLLED IN THE PHASE I CLINICAL TRIALFOR THE DENOCABTAGENE CILOLEUCEL INJECTION

Nov 7, 2023 04:30 ET

IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023

Nov 3, 2023 05:23 ET